Between August and September of this year, the Government expects to complete agreements with at least three pharmaceutical laboratories aimed at the search for the coronavirus vaccine and which include conducting clinical trials in Peru,
affirmed on Tuesday.
"This way, we will ensure preferential prices and favorable conditions to access the vaccines," he expressed.
The Cabinet chief said that timely access to the vaccine against COVID-19 is a national goal. Therefore, various efforts are undertaken in coordination with other public sector institutions, the academic community and the private sector.
Likewise, the high-ranking official reported that President Martin Vizcarra's administration is making arrangements with various governments as well as the most important pharmaceutical laboratories from Germany, Brazil, China, the United States, France, Great Britain, India, Italy and Japan to gain access to the vaccine.
Before August 31 Peru must declare the financial commitment to CovaxFacility, in order to ensure the purchase of vaccines and thereby guarantee the immunization of 6.6 million Peruvians (20% of the population).
Similarly, before the end of this year, Peru is scheduled to sign at least five agreements with the most prestigious laboratories for the completion of advance purchases and eventual technology transfer commitments, which guarantee the immunization of the remaining 50% of the population not covered by CovaxFacility.
At the national level, he commented that the Government has been supporting the project led by Cayetano Heredia University (UPCH) and Farvet Laboratory to access international opportunities that allow them to continue with the development of a vaccine which is currently in the testing phase in animals (alpacas).
He explained that this initiative mobilizes financing for research projects on possible vaccines and subsequent access to them by the countries that participate in this mechanism, especially those with low resources and middle income, such as Peru.